PROCESS FOR PRODUCING ROSUVASTATIN SALT

The subject of the present invention is an improved process for the preparation of (+)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-(3i-,55)-dihydroxy-hept-6-enoic acid zinc salt (2:1), which allows the reproducible manufacture of said compound on industrial sca...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BARTHA FERENC, KIRALY IMRE, NAGY KALMAN DR, MEZEI TIBOR DR, RUZSICS GYOERGY, BARKOCZY JOZSEF, VOLK BALAZS, KARASZ ADRIENN, TOEMPE PETER DR, SIMIG GYULA DR, VAGO PAL DR
Format: Patent
Sprache:eng ; hun
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BARTHA FERENC
KIRALY IMRE
NAGY KALMAN DR
MEZEI TIBOR DR
RUZSICS GYOERGY
BARKOCZY JOZSEF
VOLK BALAZS
KARASZ ADRIENN
TOEMPE PETER DR
SIMIG GYULA DR
VAGO PAL DR
description The subject of the present invention is an improved process for the preparation of (+)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-(3i-,55)-dihydroxy-hept-6-enoic acid zinc salt (2:1), which allows the reproducible manufacture of said compound on industrial scale in high purity. The compound of the Formula (I) can be used for the treatment of diseases related to lipid metabolism.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HUP0700667A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HUP0700667A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HUP0700667A23</originalsourceid><addsrcrecordid>eNrjZFAPCPJ3dg0OVnDzD1IAsl1CnT393BWC_INDwxyDQxxDPP0Ugh19QngYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSbxHaICBuYGBmZm5o5ExMWoAErkkdg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PROCESS FOR PRODUCING ROSUVASTATIN SALT</title><source>esp@cenet</source><creator>BARTHA FERENC ; KIRALY IMRE ; NAGY KALMAN DR ; MEZEI TIBOR DR ; RUZSICS GYOERGY ; BARKOCZY JOZSEF ; VOLK BALAZS ; KARASZ ADRIENN ; TOEMPE PETER DR ; SIMIG GYULA DR ; VAGO PAL DR</creator><creatorcontrib>BARTHA FERENC ; KIRALY IMRE ; NAGY KALMAN DR ; MEZEI TIBOR DR ; RUZSICS GYOERGY ; BARKOCZY JOZSEF ; VOLK BALAZS ; KARASZ ADRIENN ; TOEMPE PETER DR ; SIMIG GYULA DR ; VAGO PAL DR</creatorcontrib><description>The subject of the present invention is an improved process for the preparation of (+)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-(3i-,55)-dihydroxy-hept-6-enoic acid zinc salt (2:1), which allows the reproducible manufacture of said compound on industrial scale in high purity. The compound of the Formula (I) can be used for the treatment of diseases related to lipid metabolism.</description><language>eng ; hun</language><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090528&amp;DB=EPODOC&amp;CC=HU&amp;NR=P0700667A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090528&amp;DB=EPODOC&amp;CC=HU&amp;NR=P0700667A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BARTHA FERENC</creatorcontrib><creatorcontrib>KIRALY IMRE</creatorcontrib><creatorcontrib>NAGY KALMAN DR</creatorcontrib><creatorcontrib>MEZEI TIBOR DR</creatorcontrib><creatorcontrib>RUZSICS GYOERGY</creatorcontrib><creatorcontrib>BARKOCZY JOZSEF</creatorcontrib><creatorcontrib>VOLK BALAZS</creatorcontrib><creatorcontrib>KARASZ ADRIENN</creatorcontrib><creatorcontrib>TOEMPE PETER DR</creatorcontrib><creatorcontrib>SIMIG GYULA DR</creatorcontrib><creatorcontrib>VAGO PAL DR</creatorcontrib><title>PROCESS FOR PRODUCING ROSUVASTATIN SALT</title><description>The subject of the present invention is an improved process for the preparation of (+)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-(3i-,55)-dihydroxy-hept-6-enoic acid zinc salt (2:1), which allows the reproducible manufacture of said compound on industrial scale in high purity. The compound of the Formula (I) can be used for the treatment of diseases related to lipid metabolism.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAPCPJ3dg0OVnDzD1IAsl1CnT393BWC_INDwxyDQxxDPP0Ugh19QngYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSbxHaICBuYGBmZm5o5ExMWoAErkkdg</recordid><startdate>20090528</startdate><enddate>20090528</enddate><creator>BARTHA FERENC</creator><creator>KIRALY IMRE</creator><creator>NAGY KALMAN DR</creator><creator>MEZEI TIBOR DR</creator><creator>RUZSICS GYOERGY</creator><creator>BARKOCZY JOZSEF</creator><creator>VOLK BALAZS</creator><creator>KARASZ ADRIENN</creator><creator>TOEMPE PETER DR</creator><creator>SIMIG GYULA DR</creator><creator>VAGO PAL DR</creator><scope>EVB</scope></search><sort><creationdate>20090528</creationdate><title>PROCESS FOR PRODUCING ROSUVASTATIN SALT</title><author>BARTHA FERENC ; KIRALY IMRE ; NAGY KALMAN DR ; MEZEI TIBOR DR ; RUZSICS GYOERGY ; BARKOCZY JOZSEF ; VOLK BALAZS ; KARASZ ADRIENN ; TOEMPE PETER DR ; SIMIG GYULA DR ; VAGO PAL DR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HUP0700667A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; hun</language><creationdate>2009</creationdate><toplevel>online_resources</toplevel><creatorcontrib>BARTHA FERENC</creatorcontrib><creatorcontrib>KIRALY IMRE</creatorcontrib><creatorcontrib>NAGY KALMAN DR</creatorcontrib><creatorcontrib>MEZEI TIBOR DR</creatorcontrib><creatorcontrib>RUZSICS GYOERGY</creatorcontrib><creatorcontrib>BARKOCZY JOZSEF</creatorcontrib><creatorcontrib>VOLK BALAZS</creatorcontrib><creatorcontrib>KARASZ ADRIENN</creatorcontrib><creatorcontrib>TOEMPE PETER DR</creatorcontrib><creatorcontrib>SIMIG GYULA DR</creatorcontrib><creatorcontrib>VAGO PAL DR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BARTHA FERENC</au><au>KIRALY IMRE</au><au>NAGY KALMAN DR</au><au>MEZEI TIBOR DR</au><au>RUZSICS GYOERGY</au><au>BARKOCZY JOZSEF</au><au>VOLK BALAZS</au><au>KARASZ ADRIENN</au><au>TOEMPE PETER DR</au><au>SIMIG GYULA DR</au><au>VAGO PAL DR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PROCESS FOR PRODUCING ROSUVASTATIN SALT</title><date>2009-05-28</date><risdate>2009</risdate><abstract>The subject of the present invention is an improved process for the preparation of (+)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-(3i-,55)-dihydroxy-hept-6-enoic acid zinc salt (2:1), which allows the reproducible manufacture of said compound on industrial scale in high purity. The compound of the Formula (I) can be used for the treatment of diseases related to lipid metabolism.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; hun
recordid cdi_epo_espacenet_HUP0700667A2
source esp@cenet
title PROCESS FOR PRODUCING ROSUVASTATIN SALT
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T23%3A49%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BARTHA%20FERENC&rft.date=2009-05-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHUP0700667A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true